All Cardiometabolic disease articles
-
NewsHaving COVID-19 is associated with lower subsequent development of type 1 diabetes among those aged under 30 years
New research shows that people who have had COVID-19 have a lower, rather than higher, risk of subsequent development of type 1 diabetes (T1D). Furthermore, the effect is evident only in people who did not receive the SARS-CoV-2 vaccine.
-
NewsTraditional Chinese medicine compound shows promise against ischemic stroke by targeting the gut-brain axis
Researchers have uncovered new evidence that a polysaccharide derived from the traditional medicinal herb Astragalus membranaceus (Huangqi) can protect against ischemic stroke by acting through an unexpected route: the gut.
-
NewsAdults living with HIV are at high risk for diabetes. Here’s why.
A new study helps explain why people with HIV remain at elevated risk for type 2 diabetes despite effective suppression of the virus with modern medications.
-
NewsResearchers find link between gut bacteria byproduct and irregular heart rhythm
A study shows a connection between elevated blood levels of TMAO (trimethylamine N-oxide) — a byproduct of gut bacteria digestion of nutrients found in red meat and other animal products — and a higher risk of atrial fibrillation.
-
NewsNovel pathway suggests gut microbiome could be harnessed to lower blood pressure
The gut microbiome could potentially be harnessed to help lower blood pressure, according to a new study that identifies a previously unknown gut microbiota-bile acid signaling pathway targeting hypertension.
-
NewsHow did the COVID-19 pandemic shift seasonal surges of other respiratory diseases?
A new analysis explores what underlies shifts in the timing of seasonal surges of respiratory diseases, as well as shifts in surges of heart-related deaths, that occurred after the COVID-19 pandemic began.
-
NewsGut microbiota can predict risk of type 2 diabetes years before it develops
The presence of certain bacteria in the gut microbiota, and fluctuations in a person’s metabolism, can be seen in people who go on to develop type 2 diabetes years later, paving the way for identifying people at risk of developing type 2 diabetes at an early stage.
-
NewsHow psychological stress alters gut microbes and ages blood stem cells in mice
Psychological stress is recognized as a risk factor for certain health conditions. Researchers describe a mechanism in mice that explains this association: psychological stress speeds up aging-like changes in the body’s blood-forming stem cells in the bone marrow by altering the intestinal microbiota.
-
NewsGrowing evidence that sugar substitutes disrupt gut health and metabolism
In a new review, researchers noted that artificial and other low-calorie sweeteners, compared to non-caloric controls such as water or placebo, raised fasting insulin and HbA1c, a marker of long-term blood sugar control, and showed a trend toward worsening insulin sensitivity.
-
NewsDiabetes worsens long COVID complications
In a study involving 870 participants, people with diabetes took longer to recover from the virus and experienced more severe cardiac complications, as well as greater physical and cognitive difficulties.
-
NewsDietary fiber supplement shows promise for fatty liver, with effects linked to gut microbiota
A study investigating the effects of prebiotic xylo-oligosaccharides (XOS) on fatty liver in humans suggest that the fiber supplement may reduce harmful metabolic byproducts in the gut and improve liver health. The composition of the gut microbiota prior to supplementation influences the benefits observed.
-
NewsCohabitating people share about a quarter of their gut and oral microbiota
People who live together share more oral and gut microbes with each other than with other people in their communities, according to a study. Researchers also found a link between more transmissible microbes and health, particularly type 2 diabetes.
-
NewsMetformin given during acute COVID-19 infection reduced risk of clinician-diagnosed long Covid by 50%
New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that metformin, a widely available and inexpensive medication with an established safety record, reduced the risk of clinician-diagnosed long COVID when started during acute COVID-19 infection.
-
NewsSugar-free diets may disrupt gut microbiome
Eliminating sugar from your diet may be more detrimental than previously thought, according to an animal study. Mice fed a sucrose-free diet developed impaired glucose control, insulin resistance, gut microbial imbalance, intestinal inflammation and fatty liver changes, despite having no significant differences in body weight compared with control mice.
-
NewsGLP-1s may alleviate depression in mice through the microbiome
Some people taking GLP-1 drugs for diabetes and obesity experience mental health benefits. In a mouse model study, researchers report that these improvements appear to result from gut microbiome changes that lead to an abundance of a microbe strain known to have a favorable effect on neurons related to stress.
-
NewsInfections are major ‘health hazard’ for people with diabetes
Infections should be considered a “health hazard” in people living with diabetes, with experts warning that current clinical guidelines fail to reflect a substantial but under-recognised burden of illness, hospitalisation and death. People living with type 1 diabetes, type 2 diabetes and prediabetes face higher risks of infection compared to those without diabetes.
-
NewsMaternal infection: A critical driver of offspring cardiac dysfunction
A new study reveals that maternal infection causes severe metabolic disturbances within the offspring’s heart, most notably enriching differentially expressed genes in lipid, energy, and amino acid metabolism. The infection also heavily suppressed cardiac cell proliferation.
-
NewsHeart health may have impacted the risk of severe COVID-19 infection during the pandemic
Adults with highest heart health scores at the beginning of the pandemic were nearly half as likely to be hospitalized or die from COVID-19 when compared to those with the lowest scores, according to new research.
-
NewsNew clinical study shows pasteurized Akkermansia muciniphila MucT supports weight loss maintenance
A clinical trial demonstrates that supplementation with pasteurized Akkermansia muciniphila MucT® significantly improved weight loss maintenance in adults with overweight or obesity following an initial weight loss intervention.
-
NewsResearchers link human molecular, microbial diversity with geography, ethnicity
Researchers at the Stanford School of Medicine have found that ethnicity and geography may influence human molecular makeup — from metabolism and immunity to gut microbiota and biological aging. The findings, which published in Cell on May 14, illuminate the complex interplay between genetics and the environment, ...